NCT07061093View on ClinicalTrials.gov

Prospective Evaluation on the Role Exerted by Hormonal Contraceptives on 24-h Blood Pressure. A Prospective Observational Study

RecruitingOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions
Cardiovascular System Diseases (&Amp; [Cardiac])
Interventions
DRUG

Ethynyl estradiol and Drospirenone

Oral ethynyl estradiol (20 mcg) and 3 mg drospirenone for 24 days and 4 days free of hormones

DRUG

Drospirenone

A drospirenone (4mg) only pill

DRUG

Estetrol and Drospirenone

Oral estetrol (15 mg) and drospirenone (3 mg) for 24 days and 4 days of interval free of hormone

Trial Locations (1)

16132

RECRUITING

Ospedale San Martino, Genova

All Listed Sponsors
lead

Ospedale Policlinico San Martino

OTHER